Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511537
Status:
COMPLETED
Last Update Posted:
2013-08-02
First Post:
2007-08-02
Brief Title:
Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Study Overview
Official Title:
Standard of Care Trial Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study performs HLA matched stem cell transplantation from unrelated donors in adults who require stem cell transplantation but do not have a matched related donor available The incidence of graft-versus-host disease in unrelated stem cell transplantation is recorded This study also monitors the activity and toxicity of total body irradiation and cyclosphosphamide followed by stem cell transplantation from matched unrelated donors
Detailed Description:
This protocol identifies a standard-of-care method for unrelated stem cell transplantation in adults Performing this service in a consistent and documented fashion allows investigators to obtain informed consent from recipients Data is tabulated locally for quality-control comparisons with nationally-reported standards As a condition of maintaining transplant center status and to have acess to NMDP-registered donors UCSF submits clinical and outcome data to the NMDP As a result UCSF is contributing to the resolution of remaining uncertainties regarding particular transplantation practices
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None